1997
Long-term Perspective on the Prevalent-Cohort Biases in Studies of Human Immunodeficiency Virus Progression
Alcabes P, Pezzotti P, Phillips A, Rezza G, Vlahov D. Long-term Perspective on the Prevalent-Cohort Biases in Studies of Human Immunodeficiency Virus Progression. American Journal Of Epidemiology 1997, 146: 543-551. PMID: 9326431, DOI: 10.1093/oxfordjournals.aje.a009312.Peer-Reviewed Original ResearchConceptsPSP cohortRelative riskSeroincident cohortHIV infectionPrevalent cohortAIDS riskAcquired immunodeficiency syndrome (AIDS) diagnosisHuman immunodeficiency virus (HIV) infectionDisease Control case definitionHuman immunodeficiency virus (HIV) progressionImmunodeficiency syndrome diagnosisImmunodeficiency virus infectionPrevalent HIV infectionProportional hazards regressionAmbulatory care clinicsRate of progressionStudies of cohortsItalian National RegistryAIDS-free subjectsObserved relative riskSeroconversion datesHIV seroconversionCare clinicsHazards regressionNational registry
1992
Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?
ALCABES P, VLAHOV D, ANTHONY J. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading? Addiction 1992, 87: 47-54. PMID: 1311973, DOI: 10.1111/j.1360-0443.1992.tb01899.x.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivityDrug usersTreatment programHuman immunodeficiency virus (HIV) infectionHIV-1 seroprevalenceImmunodeficiency virus infectionHuman immunodeficiency virusDrug use characteristicsCommunity-based sampleDrug use behaviorsImmunodeficiency virusPossible selection biasRisk factorsVirus infectionType 1SeropositivityTreatmentCommunity service agenciesConfidential interviewsSelection biasSubjectsUse behaviorsExtensive distributionCorrelates
1991
New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1
Anthony J, Vlahov D, Nelson K, Conn S, Astemborski J, Solomon L. New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1. American Journal Of Epidemiology 1991, 134: 1175-1189. PMID: 1746528, DOI: 10.1093/oxfordjournals.aje.a116021.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBaltimoreBiasCausalityCocaineConfounding Factors, EpidemiologicFemaleHealth BehaviorHIV InfectionsHIV SeroprevalenceHIV-1HumansLogistic ModelsMiddle AgedPredictive Value of TestsPrevalenceProspective StudiesSexual BehaviorSubstance Abuse, IntravenousSurveys and QuestionnairesConceptsIntravenous drug usersDrug treatment programsCocaine injectorsDrug usersHIV seroprevalenceHIV infectionHuman immunodeficiency virus type 1 (HIV-1) infectionTreatment programActive intravenous drug usersHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Preliminary prospective dataIntravenous cocaine useType 1 infectionReceptive anal intercourseMultiple logistic regressionRisk of infectionVirus type 1HIV seroconversionPresent studyExcess riskProspective dataIntravenous usePresent study sample